Patents by Inventor Marcelo de Lima

Marcelo de Lima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Senecavirus A virus strains and immunogenic compositions therefrom
    Patent number: 12514917
    Abstract: The present invention is directed to novel nucleotide sequences of Senecavirus A (“SVA”), including novel genotypes thereof, which are useful as live attenuated and other vaccine compositions for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine SVA genotypes and isolates. Diagnostic and therapeutic sequences are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full length SVA genomes that can replicate efficiently in host animals and tissue culture.
    Type: Grant
    Filed: July 15, 2020
    Date of Patent: January 6, 2026
    Assignee: SOUTH DAKOTA BOARD OF REGENTS
    Inventors: Diego G. Diel, Marcelo de Lima, Maureen H.V. Fernandes, Bishwas Sharma
  • SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM
    Publication number: 20220249650
    Abstract: The present invention is directed to novel nucleotide sequences of Senecavirus A (“SVA”), including novel genotypes thereof, which are useful as live attenuated and other vaccine compositions for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine SVA genotypes and isolates. Diagnostic and therapeutic sequences are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include polynucleotide constructs that replicate in tissue culture and in host swine. The invention also provides for novel full length SVA genomes that can replicate efficiently in host animals and tissue culture.
    Type: Application
    Filed: July 15, 2020
    Publication date: August 11, 2022
    Inventors: Diego G. Diel, Marcelo de Lima, Maureen H.V. Fernandes, Bishwas Sharma